Gynecologic Medicine Service

People

  1. Zamarin
    Zamarin
  2. Zlobinsky
    Zlobinsky
  3. Aghajanian
    Aghajanian
  4. Kyi
    Kyi
  5. Konner
    Konner
  6. Hensley
    Hensley
  7. Grisham
    Grisham
  8. Green
    Green
  9. Makker
    Makker
  10. O'Cearbhaill
    O'Cearbhaill
  11. Guo
    Guo
  12. Friedman
    Friedman
  13. Troso-Sandoval
    Troso-Sandoval
  14. Tew
    Tew
  15. Schram
    Schram

Description

Publications

  1. Journal of Clinical Oncology (394)
  2. Gynecologic Oncology (331)
  3. International Journal of Gynecological Cancer (107)
  4. Annals of Oncology (87)
  5. Clinical Cancer Research (59)
  6. Cancer Research (55)
  7. The Oncology Report (38)
  8. Cancer (33)
  9. Journal of Geriatric Oncology (33)
  10. Journal for ImmunoTherapy of Cancer (31)

Publishers

  1. Elsevier Inc. (448)
  2. American Society of Clinical Oncology (421)
  3. Lippincott Williams & Wilkins (133)
  4. American Association for Cancer Research (109)
  5. Oxford University Press (97)
  6. Nature Publishing Group (70)
  7. Springer (50)
  8. Wiley Blackwell (48)
  9. American Association for Cancer Research (45)
  10. International Medical News Group LLC (38)

Belongs to

Types of Work

Recent Works

  1. 3D genomics identify alternate mechanisms of homologous recombination deficiency in uterine sarcoma
    Meeting Abstract

    Chiang, S.; Hensley, M. L.; Vasudevaraja, V.; Tran, I.; Yang, Y.; Stewart, C. J. R.; Park, K. J.; Ellenson, L. H.; Sikkink, K.; Schmitt, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  2. Durvalumab with paclitaxel/carboplatin (PC) and bevacizumab (bev), followed by maintenance durvalumab, bev, and olaparib in patients (pts) with newly diagnosed advanced ovarian cancer (AOC) without a tumor BRCA1/2 mutation (non-tBRCAm): Results from the randomized, placebo (pbo)-controlled phase III DUO-O trial
    Meeting Abstract

    Harter, P.; Trillsch, F.; Okamoto, A.; Reuss, A.; Kim, J. W.; Rubio-PeĢrez, M. J.; Vardar, M. A.; Scambia, G.; Tredan, O.; Nyvang, G. B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  3. Efficacy and safety of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2expressing solid tumors: DESTINY-PanTumor02 (DP-02) interim results
    Meeting Abstract

    Meric-Bernstam, F.; Makker, V.; Oaknin, A.; Oh, D. Y.; Banerjee, S. N.; Martin, A. G.; Jung, K. H.; Lugowska, I. A.; Manso, L.; Manzano, A.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save